McKesson (MCK) Reaffirms FY19 Guidance, Preliminary Guidance for Q1 Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to McKesson (MCK) Reaffirms FY19 Guidance, Preliminary Guidance for Q1 Tops Views
June 29, 2018 7:42 AM EDT
Cowen reiterated an Outperform rating and $174.00 price target on McKesson (NYSE: MCK) following the company's investor day. Management is focused on driving cost savings and emphasized its increased exposure to growth areas, namely manufacturer services, specialty and retail pharmacy.
MCK fell short of... More
June 29, 2018 7:39 AM EDT
RBC Capital lowered its price target on McKesson (NYSE: MCK) to $158.00 (from $171.00) while maintaining a Sector Perform rating.
Analyst George Hill notes the company's investor day that was largely overshadowed by the entry of Amazon into the pharma supply... More
June 28, 2018 8:47 AM EDT
By Ankur Banerjee and Bill Berkrot
(Reuters) - Amazon.com Inc said on Thursday it would buy small online pharmacy PillPack, a move that will put the world's biggest online retailer in direct competition with drugstore chains, drug distributors and pharmacy benefit managers.
The deal's potential to disrupt major players across the drug supply chain nationwide prompted a sell-off in shares of possible rivals, while sending Amazon shares up 2.5 percent.
PillPack supplies pre-sorted prescription drugs and other services to people who take multiple medications, a growing market as the U.S. population ages and requires treatment for... More
